Scientists sniff out new path to protect babies from whooping cough
NCT ID NCT01188512
First seen Jan 05, 2026 · Last updated Apr 10, 2026 · Updated 13 times
Summary
This early-stage study tested a new type of whooping cough vaccine given as a single spray in the nose. The goal was to see if it was safe and if it triggered an immune response in 48 healthy adult male volunteers. If successful, this approach could one day lead to a simple, single-dose vaccine to protect newborn babies before they start their regular vaccination schedule.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERTUSSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Karolinska University Hospital
Solna, 171 76, Sweden
Conditions
Explore the condition pages connected to this study.